Advantage Alpha Capital Partners LP Aurinia Pharmaceuticals Inc. Transaction History
Advantage Alpha Capital Partners LP
- $299 Million
- Q3 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 20,849 shares of AUPH stock, worth $320,032. This represents 0.08% of its overall portfolio holdings.
Number of Shares
20,849
Previous 24,079
13.41%
Holding current value
$320,032
Previous $203,000
13.3%
% of portfolio
0.08%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding AUPH
# of Institutions
269Shares Held
69.3MCall Options Held
984KPut Options Held
574K-
Tang Capital Management LLC San Diego, CA11.3MShares$174 Million5.69% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$142 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.9 Million2.74% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.37MShares$51.8 Million0.03% of portfolio
-
State Street Corp Boston, MA2.69MShares$41.3 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...